The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
In addition, a German court found in December that German NIPT company Cenata infringes Streck's patent.
The firm's EpiSwitch test for blood-based diagnosis of prostate cancer will be evaluated as part of the ongoing PROSTAGRAM trial.
The companies will initially work on a shotgun metagenomic sequencing-based service for microbiome research that will be offered internationally.
Early-access users of the Flongle said the small, inexpensive flow cells allow them to develop new methods quickly and to check the quality of clones and libraries.
The agriculture company said it will use the technology it has licensed for new applications in crop editing and for research to bring new foods to market.
Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.
A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.
At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.
In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.